In The News is a roundup of stories from The Canadian Press designed to kickstart your day. Here is what's on the radar of our editors for the morning o.
Since the pandemic began, the provincial government has put more than $4 million into VIDO-InterVac, which is at the University of Saskatchewan.
Both Canadian-made vaccines have yet to be approved. VIDO s COVID-19 vaccine, which was developed in the Saskatoon lab, has begun clinical trials. Moe said the earliest the Providence vaccine will arrive is by the end of the year, while VIDO-InterVac s vaccine could come early next year.
Saskatchewan and the federal government have both committed to vaccinating the general population before then.
WATCH
Manitoba premier says province s deal to secure made-in-Canada vaccines is insurance
CBC News Manitoba2 months ago
1:02Manitoba Premier Brian Pallister said Thursday the province has struck a deal to buy two million doses of a Canadian-made COVID-19 vaccine, on the condition it gets approved for use in Canada and is delivered by the end of the year.1:02
Article content
As Canada fell to 39th place in the world Thursday in the race to vaccinate its citizens against COVID-19, premiers are taking vaccination procurement into their own hands after significant stumbles by the federal government.
On Thursday, Manitoba Premier Brian Pallister announced that he entered into a deal with Providence Therapeutics, a Calgary-based biotechnology firm, to purchase two million doses of its locally produced vaccine because Ottawa has faced issues in procuring steady supplies of the existing Pfizer-BioNTech and Moderna vaccines.
We apologize, but this video has failed to load.
Try refreshing your browser, or Corbella: Kenney must seize chance to get local COVID vaccine and diversify economy Back to video